Large Molecule Bioanalysis

Advance Your Therapy With Our Dedicated Team

Work with a team of experts at the forefront of analytical testing for the next generation of biotherapeutics. WuXi Biology and Testing offers comprehensive capabilities and a sophisticated technology platform dedicated to clearing a path to more efficiently advance your biotherapies to market.

Industry-Leading Bioanalysis for Large Molecules

Our bioanalytical team has the experience and expertise to help you move your drug candidate to the next milestone. We’ll customize a program that meets your project’s evolving needs and supports you from preclinical through new drug application (NDA).

Drug-Development-Journey-1
  • Pharmacokinetics (PK) Bioanalytical Services
  • Toxicokinetics (TK) Bioanalytical Services
  • Immunogenicity ADA and Neutralizing Antibody (NAb) Service
  • Statistical analysis of Cut-Point and Low Positive Control determination
  • Exploratory and decision-making biomarker screening/discovery: Ligand Binding Assay (LBA) and LC-MS/MS Services
  • Monoclonal and Polyclonal Reagent Generation

Our Large Molecule Bioanalytical Experience

We are experts at delivering advanced bioanalytical programs customized to a specific biotherapy. Our team has years of experience executing validated assays across a range of testing platforms.

Representative Large Molecule Programs
Artboard-5-6931F1D8712A1F45D152F021

Explore Our Large Molecule Bioanalysis Services

Your ability to make intelligent, informed decisions hinges on having the right bioanalytical strategy. We can help you develop an approach that will take you from discovery through preclinical to IND and beyond – with leading efficiency and speed.

Immunogenicity Bioanalytical Services (GLP)

Biological drugs pose unique challenges during development, particularly their higher likelihood of triggering an immune response compared to small molecule drugs, which can result in adverse effects. Regulatory agencies mandate comprehensive immunogenicity testing, and paying attention to this critical component in your IND package can help prevent significant clinical delays. We partner with our clients to develop tailored reagents and assays that assess and predict key immune response markers. Our expert team also provides comprehensive support in implementing multi-tiered testing strategies that comply with the latest regulatory immunogenicity guidelines.

Immunogenicity-Assessment

Screening Confirmatory & Titer Determination

We’re experts in the screening, confirmatory, and titer determination processes for biological therapeutics. We provide advanced assays, statistical analysis, and precise results, ensuring high drug tolerance and compliance with U.S. regulatory agency standards.

  • Reagent generation to fit biological therapeutic using monoclonal or polyclonal antibodies for positive controls and epitope-specific reagent purification
  • Anti-drug antibody (ADA) electrochemiluminescent (ECL) bridging assays with capabilities of executing complex assays for difficult biotherapeutics
  • Statistical analysis of cut-point and low positive controls in report format acceptable to U.S. regulatory agencies
  • Non-cell-based neutralizing antibody (NAb) assays
  • High drug tolerance with bead extraction and acid dissociation (BEAD)
  • Cell-based neutralizing antibody assays
Approach-Immunogenicity

Regulatory Support

Get broad and deep regulatory guidance and support throughout every stage of your development process.

  • GLP/non-GLP bioanalytical facilities
  • Central laboratory services – safety lab and clinical kits
  • Support for innovator and biosimilar drugs
  • Clinical and preclinical study support
  • Submitted data accepted by worldwide health authorities
  • Completed U.S. regulatory agency, EMA, PMDA, NMPA (CFDA) study inspections with minor observations and no deficiencies
  • Completed multiple GLP inspections and certifications by OECD
  • Successfully complete 50+ client inspections each year
  • Drug Enforcement Agency-inspected, state licensed for radioactivity use (U.S.)

Explore More in Large Molecule Bioanalysis

Discovery and Non-GLP Bioanalysis

Expert non-GLP bioanalytical solutions to accelerate drug discovery.

Learn More

Preclinical Bioanalysis (GLP)

Preclinical bioanalytical support for successful IND submission.

Learn More

Clinical Bioanalysis

Global clinical study support to advance your compound.

Learn More
Explore Solutions

Explore Solutions for Your Program

Explore solutions by development phase, drug modality, therapeutic area, or integrated discovery needs.

Get A Quote

Get a Quote

Ready to plan your next study? Share your program needs with our team for a tailored estimate.

Large Molecule Bioanalytical FAQ

Get a Quote